Prostate Cancer - Results from #1480

ArteraAI Receives Medicare Payment Rate for the ArteraAI Prostate Cancer Test January 16, 2024

Improving physical activity among prostate cancer survivors through a peer-based digital walking program. January 16, 2024

Diagnostic accuracy of bone scan at different PSA levels in biochemical recurrence of prostate cancer. January 16, 2024

Defining the role of multiparametric MRI in predicting prostate cancer extracapsular extension. January 16, 2024

A Phase II Prospective Blinded Trial of MRI and In-Bore Biopsy in Active Surveillance for Prostate Cancer. January 16, 2024

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study. January 16, 2024

Telemedicine in urologic oncology care: Will telemedicine exacerbate disparities? January 16, 2024

The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study. January 16, 2024

Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer. January 16, 2024

Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer Patients: A Systematic Review. January 16, 2024

Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry. January 15, 2024

Development of PARP inhibitors in advanced prostate cancer. January 15, 2024

Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer. January 15, 2024

Long-term outcomes of pelvic-fascia sparing robotic-assisted radical prostatectomy versus standard technique: Superior urinary function and quality of life without compromising oncologic efficacy in a single-surgeon series. January 15, 2024

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. January 15, 2024

Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3. January 15, 2024

Temporal trends in cardiovascular burden among patients with prostate cancer receiving androgen deprivation therapy: a population-based cohort study. January 12, 2024

Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis. January 12, 2024

Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation. January 12, 2024

Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer. January 12, 2024

Page 75 of 1435